Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
VirCoV+
Relevance of the Multiplex PCR Approach for Severe Respiratory Infections of Patients Hospitalized - Including an Intensive Care Unit, During the COVID-19 Pandemic
1 other identifier
observational
18
1 country
1
Brief Summary
The hypothesis was that a retrospective investigation of the molecular virological tests in a University hospital could be informative, with the aim to identify non-COVID-19 respiratory viruses during the circulation of SARS-CoV-2, according to systematic population data for public health knowledge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2024
CompletedFirst Submitted
Initial submission to the registry
April 4, 2024
CompletedFirst Posted
Study publicly available on registry
April 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedFebruary 18, 2025
April 1, 2024
1 month
April 4, 2024
February 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of positive viral PCR assays (not COVID-19) from hospitalizations for respiratory infections.
Number of patients with positive virological molecular tests (multiplex respiratory panels) from the beginning of 2021 to mid-2022, with the nature of the viruses detected and the chronology of occurrence of positive tests.
18 months, retrospectively
Secondary Outcomes (1)
Real-life features of patients in Intensive care (from the whole population - Outcome 1) with positive viral PCR during infectious pneumonia.
18 months, retrospectively
Study Arms (1)
18 ICU-patients group
18 ICU (Intensive Care Unit)-patients group, from the whole population of patients (1,614) who were hospitalized for respiratory infections from early 2021 to mid-2022 in Nancy University hospital, France.
Interventions
For 18 ICU patients, retrospective collection of routine bioclinical database (ICCA db)
Eligibility Criteria
18 Intensive Care Unit (ICU)-patients, from the whole population of patients who were hospitalized for respiratory infections from early 2021 to mid-2022 in Nancy University hospital, France: * from the results of the multiplex FilmArrays PCR tests carried out during the 18 months of the study; * for the ICU files, 18 patients positive for virus by the FilmArray Pneumonia test: ICU patients (or representatives) informed of the data collection that can be used for research (ICCA db)
You may qualify if:
- For adult patients, or minors 'via' parents, able to give consent - 18 intensive care patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Schvoerer
Vandœuvre-lès-Nancy, 54511, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 4, 2024
First Posted
April 5, 2024
Study Start
April 1, 2024
Primary Completion
May 1, 2024
Study Completion
June 1, 2024
Last Updated
February 18, 2025
Record last verified: 2024-04